Pneumatic compression versus manual lymph drainage as part of decongestive care for breast cancer–related lymphedema
Official title: Comparison of Intermittent Pneumatic Compression Therapy as an Alternative or an Adjunct to Manual Lymphatic Drainage Within Complete Decongestive Therapy for Breast Cancer-Related Lymphedema
Run by Pamukkale University · NCT07154043 · Data updated 2026-11-12
This study tests whether adding or replacing manual lymph drainage with intermittent pneumatic compression helps women with unilateral breast cancer–related arm lymphedema.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 45 (estimated) |
| Sponsor | Pamukkale University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Denizli) |
| Status | Recruiting |
| Started | September 15, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT07154043 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–65 with unilateral breast cancer–related arm lymphedema for at least six months, with >20% limb volume difference or >2 cm circumference difference, who completed primary breast cancer treatment at least six months ago and have not had recent lymphedema therapy are ideal candidates.
✕Probably not a fit
Patients with bilateral lymphedema, bilateral axillary dissection, metastatic or active cancer, stage 3 lymphedema, ongoing radiotherapy/chemotherapy, or uncontrolled serious systemic disease are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with unilateral breast cancer–related upper extremity lymphedema receive complete decongestive therapy (CDT) delivered in different ways: standard CDT including manual lymph drainage (MLD), CDT plus intermittent pneumatic compression (IPC), or CDT with IPC instead of MLD. Eligible women are adults (18–65) with at least six months of unilateral lymphedema meeting >20% limb volume or >2 cm circumference difference after mastectomy and axillary dissection. Outcomes include changes in limb volume and circumference, symptoms such as heaviness and tension, upper limb function, and quality of life measured before and after the treatment period. The trial aims to clarify whether IPC can be a useful adjunct or alternative to MLD within routine CDT.
Why it matters
Potential benefit: If effective, IPC could offer an alternative or complementary option to manual lymph drainage that reduces swelling and improves arm comfort and function.
How similar studies have gone: Previous trials comparing IPC and MLD have reported inconsistent results—some found no difference while others noted benefits of IPC for heaviness—so evidence to date is mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female gender * Patients aged 18-65 years * Having a history of unilateral mastectomy and lymph node dissection at least one year ago due to breast cancer diagnosis. * Having unilateral breast cancer-related upper extremity lymphedema (\>20% volume difference between the two upper extremities or \>2 cm difference in circumference at any measured point) according to the diagnostic criteria of the International Society of Lymphology (Committee 2023) for at least six months. * Not having received lymphedema treatment or exercise therapy for the last six months * Completing breast cancer primary treatment at least 6 months ago (except hormone therapy/aromatase inhibitors) Exclusion Criteria: * Bilateral breast cancer * Bilateral axillary lymph node dissection * Metastatic breast cancer * Receiving ongoing radiotherapy or chemotherapy * Primary or bilateral lymphedema * Having active cancer * Presence of stage 3 lymphedema * Uncontrolled serious systemic disease (cardiopulmonary diseases, arterial or venous diseases, renal dysfunction, uncontrolled hypertension or hypotension, cardiac arrhythmia, scleroderma, Sudek's atrophy). * Current or recent (within the last 3 months) infection (cellulitis, lymphangitis) or deep venous thrombosis * Presence of open wounds * Using medications that may affect body fluid and electrolyte balance (diuretics, etc.). * Individuals with serious mental and sensory problems * Being pregnant * Body mass index \>40 kg/m2
Where it's running
-
Pamukkale University
Denizli, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Emre Bezmez, M.D.
- Email: emrebezmez@gmail.com
- Phone: +905319902220
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ESWT added to standard lymphedema care for breast cancer patients
This study tests whether adding extracorporeal shock wave therapy to standard lymphedema care helps women with unilateral Stage II breast cancer–related swelling.
-
Kinesio taping for chronic breast and truncal oedema after breast cancer treatment
This trial tests whether adding kinesio tape to standard decongestive lymphatic therapy helps women with persistent (more than 6 months) breast or truncal swelling after breast cancer treatment.
-
Effects of physiotherapy on sleep and quality of life in women with lymphedema after breast cancer
This study is testing whether special physiotherapy can help women with lymphedema after breast cancer feel better and sleep more soundly.
-
Using light therapy to manage lymphedema in breast cancer patients
This study is testing if a combination of light therapy and massage can help breast cancer patients with lymphedema reduce swelling, relieve pain, and improve their quality of life.
-
Predicting lymphedema risk in breast cancer patients
This study is testing a new tool to help doctors predict which breast cancer patients are at risk for developing lymphedema after surgery so they can take steps to prevent it.
-
Gentle Touch therapy for arm lymphedema after breast cancer surgery
We will test whether adding Gentle Touch lymphatic drainage to usual rehabilitation reduces arm swelling in women aged 30–75 with breast cancer–related lymphedema.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.